2 results match your criteria: "Baylor University Medical Center and Baylor Sammons Cancer Center[Affiliation]"
Concomitant endometrial and pancreatic cancers.
Proc (Bayl Univ Med Cent)
April 2010
Departments of Pathology (Shiller), Gynecology (Phelps), Surgery (Lamont), and Radiation Oncology (Scruggs), Baylor University Medical Center and Baylor Sammons Cancer Center, Dallas, Texas.
Clinical strategies for supporting the untransfusable hemorrhaging patient.
Proc (Bayl Univ Med Cent)
October 2009
Department of Oncology (Melmed, Holmes) and the Department of Pathology (Newhouse, Mays), Baylor University Medical Center and Baylor Sammons Cancer Center, Dallas, Texas, and the Department of Pathology, Midland Memorial Hospital, Midland, Texas (Hulsey). Dr. Melmed is now at Baylor Medical Center at Garland.
Hemorrhaging patients who cannot be transfused due to personal beliefs or the lack of compatible blood products provide a unique challenge for clinicians. Here we describe a 58-year-old African American man with a history of sickle cell-beta(+) thalassemia who had recently received a multiunit exchange transfusion and developed hematochezia followed by severe anemia. Due to the presence of multiple alloantibodies, no compatible packed red blood cell (pRBC) units could initially be located.
View Article and Find Full Text PDF